1,686
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway

, &
Pages 11909-11921 | Received 17 Sep 2021, Accepted 09 Nov 2021, Published online: 19 Dec 2021

Figures & data

Table 1. Relationship between the ITGA11 expression in GC tissue samples and clinical characteristics

Table 2. Primer sequences

Figure 1. Expression of ITGA11 in GC

A: The ITGA11 profile in cancerous and paracancerous normal tissues of 49 clinical samples was examined by qRT-PCR. B: The ITGA11 profile in five cases of cancerous and paracancerous GC tissues was verified by WB. C: The GEPIA database was adopted to verify ITGA11 expression in GC tissue. D: The effect of ITGA11 on the GC prognosis was analyzed in the human protein altas (https://www.proteinatlas.org/). E. Kaplan-Meier Plotter database (http://kmplot.com/analysis/) was adopted for analyzing the association of ITGA11 levels with overall survival, first progression and post progression survival of GC sufferers. **P < 0.01, ***P < 0.001
Figure 1. Expression of ITGA11 in GC

Figure 2. Inhibiting ITGA11 attenuated GC cell proliferation and invasion and strengthened apoptosis

ITGA11 knockdown models were constructed in MKN45 and AGS cells. A-B: qRT-PCR and WB were implemented to test the effect of ITGA11 knockdown plasmids. C-D: Cell proliferation was verified by CCK-8 and colony formation experiment. E-F: The migrative and invasive ability of MKN45 and AGS were monitored by Transwell assay. G: The profiles of Bcl-2, Bad, C-Caspase3 and Bax were monitored by WB. H: TUNEL assay was adopted to gauge the apoptosis of MKN45 and AGS cells. Ns P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. N = 3
Figure 2. Inhibiting ITGA11 attenuated GC cell proliferation and invasion and strengthened apoptosis

Figure 3. The regulatory effect of ITGA11 on the ITGA11/ PI3K/AKT pathway

LinkedOmics database (http://linkedomics.org/login.php) was used for analyzing the potential downstream targets of ITGA11. A: The positively and negatively co-expressed Top-50 genes of ITGA11 in GC were displayed in heat maps. B: The overall closely co-expressed genes of ITGA11 in GC were exhibited as a volcano plot. C-D: PI3K-AKT pathway has a potential role in ITGA11 in GC. The data was analyzed by GSEA. E-I: The LinkedOmics database analyzed the correlation between ITGA11 and PIK3CG, PIK3CD, PIK3CA, AKT2, and AKT3
Figure 3. The regulatory effect of ITGA11 on the ITGA11/ PI3K/AKT pathway

Figure 4. Inhibiting ITGA11 inactivated PI3K/AKT

ITGA11 knockdown models were established in MKN45 and AGS. A-B. WB was applied to make certain the PI3K/AKT profile in MKN45 and AGS cells. * * * P < 0.001, N = 3
Figure 4. Inhibiting ITGA11 inactivated PI3K/AKT

Figure 5. Activating PI3K repressed the effect of ITGA11 knockdown on GC progression

ITGA11 knockdown plasmids and/or IGF-1 were added to MKN45 cells. A-B: The CCK-8 assay and colony formation test were carried out to gauge cell proliferation. C-D: Cell migration and invasion were assessed by Transwell assay. E: The profiles of Bcl-2 and Bax were monitored by WB. F: WB gauged the protein levels of the PI3K/AKT axis in MKN45 cells. * P < 0.05, * * P < 0.01, * * * P < 0.001, N = 3
Figure 5. Activating PI3K repressed the effect of ITGA11 knockdown on GC progression

Figure 6. Knocking down ITGA11 dampened GC cell growth cells in vivo.

Mouse tumor models knocking down ITGA11 were constructed in MKN45 and AGS cell lines. A: Analysis of survival rates in mice. B-G: After 30 days, the nude mice were sacrificed, and their subcutaneous nodules were removed, with tumor volume and weight calculated. H: The TUNEL assay was employed to examine apoptosis in tumor tissues. I: The fluorescence intensity of the PI3K/AKT pathway was checked by tissue immunofluorescence. J: The profiles of ITGA11 and PI3K/AKT were tested by WB. * * * P < 0.001, N = 5
Figure 6. Knocking down ITGA11 dampened GC cell growth cells in vivo.